Cannabis-derived THC shows promise for treating PTSD-related nightmares

Research indicates that tetrahydrocannabinol (THC), a compound derived from cannabis, may effectively alleviate nightmares associated with post-traumatic stress disorder (PTSD). PTSD occurs when the brain cannot process traumatic experiences, causing intrusive memories and nightmares that disrupt sleep and trigger panic responses. These recurring nightmares significantly impact quality of life for trauma survivors. THC-based treatments represent a potential therapeutic avenue for patients who have not responded adequately to conventional PTSD medications. This finding offers hope for individuals struggling with trauma-related sleep disturbances and their debilitating psychological effects.